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bryA: An Unusual Modular Polyketide Synthase
Gene from the Uncultivated Bacterial Symbiont
of the Marine Bryozoan Bugula neritina
their development is often difficult due to scarcity of
supply, and solutions to this problem can be elusive. In
some cases, chemical synthesis is impractical, and not
all invertebrates are amenable to aquaculture. Finally,
cultivation of symbionts suspected as biosynthetic
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Bryostatins are a family of cytotoxic macrolides found
in the marine bryozoan, Bugula neritina (Figure 1). They“Candidatus Endobugula sertula,” the uncultivated
are chemically interesting because of their unique struc-bacterial symbiont of Bugula neritina, is the proposed
tures, large size, and biological activity. Bryostatins actsource of the bryostatin family of anticancer com-
as a chemical defense for B. neritina larvae by makingpounds. We cloned a large modular polyketide syn-
them unpalatable to fish predators [3, 4]. In additionthase (PKS) gene complex from “Candidatus Endobu-
to this role, bryostatins have anticancer activity, andgula sertula” and characterized one gene, bryA, which
bryostatin 1 is in clinical trials in combination with otherwe propose is responsible for the initial steps of bryo-
chemotherapeutic agents for treatment of a variety ofstatin biosynthesis. Typical PKS domains are present.
cancers (http://www.clinicaltrials.gov) [5–16]. SeveralHowever, acyltransferase domains are lacking in bryA,
decades have elapsed between the discovery of theand -ketoacyl synthase domains of bryA cluster with
bryostatins and their clinical application because of diffi-those of PKSs with discrete, rather than integral, acyl-
culties in obtaining a supply of these scarce compounds.transferases. We propose a model for biosynthesis of
Bryostatins resemble bacterial complex polyketides,the bryostatin D-lactate starter unit by the bryA loading
suggesting that they are likely to be biosynthesized bymodule, utilizing atypical domains homologous to
a modular polyketide synthase (PKS) mechanism. Mod-FkbH, KR, and DH. The bryA gene product is proposed
ular PKSs are protein complexes that synthesize polyke-to synthesize a portion of the pharmacologically active
tide structures by a stepwise chain elongation mecha-part of bryostatin and may be useful in semisynthesis
nism and use acyl-CoA substrates as precursors. Theof clinically useful bryostatin analogs.
growing chain is attached to the complex by a
-ketothioester linkage. Each step in chain extensionIntroduction
and modification is carried out by modules consisting
of core and accessory domains with different catalyticMarine invertebrates, particularly sessile ones, are rich
activities [17, 18]. Core domains consist of a -ketoacylsources of unusual metabolites. Like terrestrial plants,
synthase (KS) and an acyl carrier protein (ACP), whichthey often rely upon chemical defense to discourage
are responsible for condensing successive acyl-CoApredation. Symbiosis with biochemically versatile mi-
substrates that are selected and activated by an acyl-croorganisms is an efficient strategy to accomplish such
transferase (AT). In an individual module, the enzymechemical defense. Microbial symbionts have often been
bound -ketothioester can be reduced at the keto groupinvoked as biosynthetic sources of natural products
to varying degrees by accessory domains. These in-found in marine invertebrates, based on structural simi-
clude, in the order in which they are used, the ketoreduc-larities to known microbial compounds. These com-
tase (KR), dehydratase (DH), and enoyl reductase (ER)pounds may have applications in a clinical setting, but
domains [17, 18]. After completion of the steps in one
module, the chain is passed on to the next. Because
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Figure 1. The Structure and Recognition Do-
main of the Bryostatins
Structure of bryostatins and the recognition
domain of bryostatin [29, 53]. Bryostatin 10
has been shown to be a feeding deterrent
in B. neritina larvae [4] and probably is the
ecologically significant compound. Bryostatin
1 is currently in clinical trials for a variety of
cancer treatments. The recognition domain
is the part of the bryostatin molecule essential
for its anticancer activity [29, 53].
ally inactive [19], whereas, in others, a single domain or Using in situ hybridizations, it was determined that KSa
gene fragment transcripts were located and expressedentire module can function in more than one round of
elongation [20]. Yet, other clusters exhibit module skip- in “Candidatus E. sertula” cells in B. neritina larvae [27].
Furthermore, the KSa gene fragment declined in abun-ping, wherein the growing polyketide chain can skip over
an entire module, allowing another level of molecular dance after antibiotic treatment that specifically re-
duced the “Candidatus E. sertula” population in B. neri-diversity [19].
B. neritina has recently been shown to be a complex tina colonies [27]. These results provided evidence that
KSa is encoded and expressed in “Candidatus E. ser-of at least three sibling species that vary in the types
of bryostatins they produce [21, 22]. There are 20 de- tula.” We hypothesized that KSa is part of a larger modu-
lar polyketide synthase-encoding complex responsiblescribed bryostatins [4, 23–26]; most of their diversity is
due to variations at the C-7 and C-20 positions (Figure for biosynthesis of the bryopyran precursor to bryostat-
ins, and that KSa could be used as a probe to isolate1). One sibling species, type D (deep), produces bryo-
statin 1 and other bryostatins with a 2,4-octadienoate the entire gene cluster. This report describes the use of
such an approach to clone the first gene of a PKS clustersubstituent at C-20 [22], whereas the other species, type
S (shallow), produces bryostatins without this addition that we believe is responsible for bryostatin synthesis.
at C-20 (Figure 1). The bryostatins of the third sibling
species, Northern Atlantic, have not been characterized. Results
Because the predominant bryostatins in the deep and
shallow species differ only in the C-20 substituent, we Enrichment of “Candidatus E. sertula” DNA
Content in Total DNAexpect that a common precursor of the bryostatins is
synthesized by a similar modular polyketide synthase Total DNA extracted from B. neritina consists of a mix-
ture of DNA from the bryozoan, epibionts, “Candidatusin both. B. neritina contains a bacterial symbiont, “Can-
didatus Endobugula sertula” (abbreviated “Candidatus E. sertula,” and potentially DNA of other associated bac-
teria. Consistent with this, examination of the bacterialE. sertula”), which is believed to be responsible for syn-
thesizing the polyketide precursor to the bryostatins community associated with the colony by amplification
of bacterial small ribosomal subunit (16S) genes, fol-[27]. Reduction or elimination of “Candidatus E. sertula”
from B. neritina colonies by antibiotic treatment of larvae lowed by denaturing gradient gel electrophoresis, re-
vealed a complex community [27]. In order to facilitatereduces bryostatin production in the new colony and
eliminates it in the next generation of larvae with no library construction and Southern blotting experiments,
we developed procedures to enrich the “Candidatuseffect on colony growth. This finding suggests that the
symbiont does not play a major nutritional role [4, 27]. E. sertula” content of DNA extracts. We used competi-
tive PCR to quantify the enrichment at different stages ofThe yield of bryostatins from B. neritina is low, and thus
far it has not been possible to cultivate “Candidatus purification, with a cloned competitor fragment derived
from the previously isolated KSa gene fragment [27].E. sertula,” limiting the supply of bryostatin. Chemical
synthesis of bryostatins is possible, but the complexity These assays indicated a 5.5-fold enrichment using dif-
ferential centrifugation to enrich for bacteria, and a totalof the procedure makes it impractical as a means to
provide a clinical supply [28]. A promising avenue is of 16-fold enrichment in particular fractions isolated
from subsequent Hoechst dye density gradients (seesynthesis of simpler analogs of bryostatins based on
the pharmacologically active portion of the molecule figure 6 in reference [1]).
(Figure 1), or “recognition domain” [29]. Another ap-
proach for obtaining part of or the entire bryopyran ring Cloning bryA
It was determined that only a total DNA preparation of B.of bryostatins, which is likely to be very cost effective,
would be to clone the bryostatin synthesis genes and neritina from Mission Bay (not “Candidatus E. sertula”-
enriched) provided DNA of sufficient size for cosmidexpress them in a heterologous host. In previous work,
we isolated and cloned a 300 bp -ketoacyl synthase cloning. A cosmid library was constructed by using total
DNA from Mission Bay B. neritina and was screenedgene fragment (KSa) from a total DNA preparation from
B. neritina by PCR with degenerate primers [27]. The KSa with the KSa gene fragment. Four positive cosmids with
inserts of 30–40 kbp were isolated and sequenced fromgene fragment was present in all B. neritina populations
tested, but not in other bryozoans, and other KSs ob- the ends and from internal restriction sites. These cos-
mids spanned a region of PKS homology of approxi-tained were only sporadically present and were pro-
posed to originate from casual bacterial associations. mately 65 kbp (the bry cluster). At this stringency, the
The Modular Polyketide Synthase Gene, bryA
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Figure 2. Genetic Analysis of the bryA
Region
(A) Map of bryA indicating locations of
probes, reverse transcription (RT)-PCR prod-
ucts, and module and domain content. The
top portion shows a restriction map; ACP-1
indicates the location of the probe used in
the Southern blot in (B). Below the map are
locations of RT-PCR products examined in
(C), and under these is a nucleotide scale bar
in kilobase pairs (kbp). Below the scale bar
are delineated the locations of the four mod-
ules in the bryA gene, and below this are the
relative arrangements of domains—these are
not precisely to scale. Domain abbreviations
are as follows: DH, dehydratase; KR, ketore-
ductase; ACP, acyl carrier protein; KS,
-ketoacyl synthase; MT, methyltransferase;
FkbH, FkbH homolog originally identified in
the ansamitocin biosynthetic cluster [31]. (B)
Southern blot hybridization of EcoRI/SalI-
digested genomic “Candidatus E. sertula”-
enriched DNA (lane 1) and cloned DNA (lane
2); radiolabeled ACP-1 is used as a probe. (C)
Agarose gel of bryA RT-PCR products de-
rived from adult Scripps Pier B. neritina RNA showing the presence of transcripts throughout the bryA ORF. Regions amplified are denoted
at the top (RT-A through D), and lanes in which the protocol included () or omitted () the reverse transcriptase are shown.
KSa probe identified cosmids spanning the entire 65 deep and shallow genotypes, a third library was pre-
pared from “Candidatus E. sertula”-enriched DNA, ex-kbp region, not just those in which KSa was located.
No clones were isolated that did not map to the bry tracted from the deep genotype from Torrey Pines Artifi-
cial Reef, cloned into Lambda ZAP (insert size aboutcluster. Two of the cosmids showed evidence of dele-
tions upon propagation. To minimize such artifacts, a 5 kb), and screened with probes from the shallow geno-
type; no clones were identified that did not originate insecond library was prepared by using “Candidatus E.
sertula”-enriched DNA of the shallow genotype from the bry cluster. Three overlapping clones spanned the
last two-thirds of the bryA gene and were fully se-Scripps pier, which was cloned into Lambda Dash and
yielded smaller inserts from 10 to 20 kbp. quenced. The upstream portion could not be isolated
from the Lambda ZAP library due to the fact that theThis library was screened repeatedly at low stringency
with probes spanning 91% of the 65 kbp bry cluster. size of the target fragment was larger than that selected
for cloning, resulting in underrepresentation in the li-A total of 53 positive clones were identified and end
sequenced, and 32 clones mapped to the bry cluster. brary. Using sequence information from the shallow ge-
notype, four overlapping PCR products were amplifiedSix were cloning artifacts, in which bry cluster Sau3A
fragments were ligated to Sau3A DNA fragments from directly from genomic DNA, which completed the deep
bryA sequence.elsewhere in the genome. These, plus the 32, represent
75% of the positive clones. Eleven clones did not contain
PKS homology on either end. These represent either Genomic Mapping
We verified that the sequence data obtained from thesmall clusters (15 kbp) or cloning artifacts. Four clones
contained PKS sequence not found in the bry cluster. cloned bryA gene sequences corresponded to restric-
tion maps of genomic DNA by using Southern blot hy-It is unknown whether these genes are linked, but if they
are, the cluster in which they originate would be small. If bridization with “Candidatus E. sertula”-enriched DNA.
Four probes were designed that spanned the bryA re-these four come from a single cluster, its representation
(7.5% of total positives) suggests that it is from a cluster gion, and the DNA was digested with seven different
combinations of restriction enzymes, of which onlyapproximately one-tenth the size of the bry cluster. Al-
though the low representation of these clones could EcoRI and SalI sites proved to be present in the bryA
region. Other enzymes that cut outside of the regionbe attributed to cloning bias, low-stringency Southern
analysis, which is not subject to this bias, corroborates confirmed the sizes of fragments at the ends of bryA.
The map deduced from the sequence corresponded tothese data (see “Genomic Mapping” below). The fact
that non-bry PKS clones were isolated demonstrates the sites observed in the genomic DNA blots. A repre-
sentative Southern blot is shown in Figure 3B, whichthat the stringency used was low enough to detect other
clusters. These results strongly suggest that the bry identifies the same size gene fragment in genomic and
cloned DNA. When probed at low stringency and exam-cluster is the only PKS in the “Candidatus E. sertula”
genome large enough to be responsible for the biosyn- ined with image enhancement, total DNA contained ad-
ditional hybridizing bands not originating in the bry clus-thesis of bryostatins.
Four overlapping lambda clones spanned the bryA ter. All but one of these are absent in “Candidatus
E. sertula”-enriched DNA, indicating that they originategene, and this region was fully sequenced from these
clones (Figure 2A). To compare the PKS region of the from environmental bacteria, not from the “Candidatus
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Table 1. Locations of Domains in the bryA Sequence
Module Domain Amino Acid Position
ML DH*-L 1–124
KR*-L 278–490
FkbH-L 518–1026
ACP-L 1131–1203
M1 KS-1 1338–1805
KR-1 2207–2393
ACP-1 2472–2543
M2 KS-2 2582–3031
KR-2 3377–3571
ACP-2 3651–3720
M3 KS-3 3778–4248
MT-3 4473–4755
ACP-3 4756–4829
to the Bacillus subtilis pksM genes and the Paederus
fuscipes symbiont ped genes. The bryA gene contains
13 identifiable domains organized into 4 modules (ML,
M1–M3) (Figure 2A). Locations of the domains (based
on amino acid position) in each module are listed in
Figure 3. Amino Acid Alignments of Conserved Regions of the bryA
Table 1. All four modules contain an ACP. M1–M3 con-PKS Domains
tain -ketoacyl synthases, and M1 and M2 each contain
Conserved amino acid sites in the bryA PKS domains [54]. Only the
a ketoreductase. M3 contains a methyltransferase (MT).regions containing proposed active sites are shown. The numbers
The loading module (ML) is quite unusual. The firstcorrespond to the amino acid position of the first residue in the first
domain in this module is most similar to a dehydratase,motif listed. Active site residues are indicated by asterisks, and
residues important for function are shown in bold. The KS-2 domains and the second is most similar to a ketoreductase; how-
with significant amino acid differences from deep (D) and shallow ever, neither are an exact match throughout their se-
(S) “Candidatus E. sertula” are annotated as such. The KR domain quence. Finally, the loading module contains a homolog
motif is underlined (GxG/AxxGxxxA). Also shown is the B-type ste- of FkbH, a gene first identified in the ansamitocin gene
reochemistry signature (LDD) for eryA KR-1; eryA KR-2 has A-type
cluster [31]. Most domains of M1–M3 appear to containstereochemistry. Domains from the erythromycin gene cluster (eryA)
the active site consensus sequences for function, in-are shown for comparison.
cluding the region with major differences between deep
and shallow, where the KS of M2 is located (Figure 3).E. sertula” genome (data not shown). The remaining
The FkbH homolog in ML and a MT domain present in
band is not large enough to encode a bryostatin cluster,
M3 are not common; however, similar domains have
and it may correspond to a non-bry PKS isolated from
been observed in other PKS systems [31–34]. Phyloge-
the Lambda Dash “Candidatus E. sertula”-enriched DNA netic analysis indicated that bryA KS domains clustered
library. with KS domains from other modular Type I PKS genes
that contain discrete acyltransferase (AT) domains, and
Sequence Analysis not with those PKS genes that contain integral ATs (Fig-
Sequence analysis indicated that bryA comprises a sin- ure 4). This is consistent with the lack of ATs in the bryA
gle open reading frame (ORF) of 14,664(deep)/14,667 sequence and suggests that one or more discrete ATs
(shallow) nucleotides, encoding 4,888(deep)/4,889(shal- are located elsewhere in the genome.
low) amino acids. The overall GC content of the gene
is low at 38%. The four non-bry PKS fragments found Native RNA Expression
through cloning also contain an overall low GC content Due to the low content of “Candidatus E. sertula” RNA
of between 32% and 42%. Although it is possible that in total RNA preparations from B. neritina, reverse tran-
these fragments originate in other bacteria associated scription PCR (RT-PCR) was used to determine if bryA
with “Candidatus E. sertula,” this result suggests that was transcribed in vivo. RT-PCR demonstrated the pres-
they probably originate in “Candidatus E. sertula” but ence of transcripts from regions A, B, C, and D of bryA
are part of one or more smaller PKS clusters. In the deep (Figures 2A and 2C). The identity of the RT-PCR products
sequence, nucleotides 9466–9468 are missing, which was confirmed by sequencing. Control RT-PCRs per-
results in the deletion of one amino acid. bryA genes formed without reverse transcriptase were negative
from the shallow and deep sibling species were very (Figure 2C), verifying that DNA contamination did not
similar, with 98.3% identity at the nucleotide level and contribute to the RT-PCR products produced with re-
97.8% at the amino acid level. The major differences verse transcriptase (Figure 2C). These results are con-
were found in one region between nucleotides 7753 sistent with transcription of the entire bryA ORF in
and 8994, where the nucleotide identity was 90.3%, as B. neritina.
opposed to 99% in the rest of the gene.
Discussion
Domain Content
Using BLAST [30] on the NCBI server, we determined The sequences of bryA from the deep and shallow spe-
cies of B. neritina are remarkably similar. The structurethat the greatest overall similarity of the bryA genes was
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Figure 4. Phylogenetic Tree of KS Amino
Acid Sequences Generated by Using Dis-
tance and Heuristic Search in PAUP
Bootstrap values for clades are displayed at
the nodes. KS domains from bryA in “Can-
didatus E. sertula” (including the KS-2 do-
mains from both deep and shallow species)
and several modular Type I PKS genes are
compared. A Type II PKS KS from S. venezua-
lae is used as the outgroup. Groupings indi-
cate modular Type I PKS gene clusters that
contain discrete AT domains (a single domain
for entire cluster) or integrated AT domains
(domains present reiteratively in all modules).
and domain organization of the genes from both species By analogy, using the same intermediate, a sequence
of three reactions catalyzed by FkbH, DH*, and KR* willis identical, and amino acid identity is very high. Al-
though one region is less conserved than the rest of the yield D-lactate (Figure 5A), the expected starter unit for
bryostatin biosynthesis. In the first reaction, the glyco-gene, all conserved residues recognized as important
for domain function in one species are conserved in the lytic pathway intermediate, presumably phosphoglyc-
erate, is transferred to ACP by the action of FkbH. Aother. The existence of such a large ORF in a symbiont
genome, where genome reduction or corruption might dehydration reaction catalyzed by DH* then occurs, gen-
erating an enzyme bound enoylpyruvate, which can eas-be expected to occur [35], and the demonstration that
the ORF is transcribed throughout its length, suggest ily rearrange to form an enzyme bound pyruvate. In the
final reaction, the KR* reduces the -keto group of py-that bryA is functional. Extensive library screening,
Southern hybridizations, and sequencing revealed no ruvate, and the system is ready for the first condensa-
tion-reduction cycle to be catalyzed by the downstreamevidence of large PKS clusters other than the bry cluster
containing bryA, suggesting that other large modular extension module in bryA (Figure 5B). This scheme is
consistent with the observation by Kerr et al. [36] thatPKSs are absent in “Candidatus E. sertula.”
A hypothesis for the function of bryA in bryostatin radiolabeled glycerol was incorporated into bryostatin,
presumably as a precursor of the 3-carbon starter unit.biosynthesis is shown in Figure 5. We propose that the
first module within bryA is a loading module, which con- In bacteria, glycerol enters into glycolysis through phos-
phorylation and oxidation to dihydroxyacetone phos-sists of four domains, including a DH homolog (DH*),
a KR homolog (KR*), FkbH, and ACP (Figure 5). FkbH phate, which in turn is isomerized to glyceraldehyde
3-phosphate. The latter is then oxidized to form phos-homologs have recently been observed in other PKS
gene clusters, and the function of FkbH has been attrib- phoglycerate.
The -ketoreduction we propose for the KR* is un-uted to catalyzing, in association with other protein com-
ponents, the formation of methoxymalonate extender usual in complex polyketide biosynthesis. Normally, a
KR in a modular PKS system catalyzes reduction ofunits from a glycolytic pathway intermediate [31, 34].
Figure 5. Proposed Involvement of BryA in
Bryostatin Synthesis
(A) The proposed pathway for D-lactate for-
mation by the bryostatin loading module.
(B) The proposed series of reactions cata-
lyzed by BryA. BryA consists of the loading
module and three chain extension modules.
The curved arrow indicates the position of
lactonization. The dashed box depicts the
part of bryostatin that BryA synthesizes.
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-ketoacyl ACP generated during elongation of the poly- M1 and M2 are proposed to catalyze formation of hy-
droxyl groups with opposite stereochemistry (Figureketide chain. Most (if not all) KR domains, including the
KR* in BryA, are most similar to a diverse family of 5B). Recent work by Caffrey [41] suggests that stereo-
chemical specificity of KRs can be identified throughenzymes collectively known as short-chain dehydroge-
nase/reductases (SDR). Enzymes included in the SDR characteristic sequence signatures. This study was
done by using KRs from Streptomycete PKSs with inte-family span several EC classes, with oxidoreductases
forming the majority [37]. When we first speculated on gral ATs. Unfortunately, analysis of KRs from discrete AT
PKSs does not support these patterns (data not shown).the reaction scheme shown in Figure 5A, the only known
groups of enzymes involving FkbH and presumably syn- However, the last aspartate in the LDD signature associ-
ated with B-type KRs of integral AT PKSs does appearthesizing a 3-carbon polyketide building unit from a gly-
colytic pathway intermediate were those reported for to be predominant in B-type KRs of discrete AT PKSs.
The proposed B-type M2 KR contains this aspartateFK520 and ansamitocin biosynthetic gene clusters [31,
34]. However, A BLAST [30] search analysis of the bryA (Figure 3). This aspartate is generally absent in A-type
KRs from discrete AT PKSs and is absent from the pro-region revealed that the amino acid sequence of the
DH*-KR* di-domain portion shows the highest similarity posed A-type M1 KR.
BryA lacks integral ATs, as has been observed in sev-to a putative didomain protein (encoded by orf19) in a
region spanning the biosynthetic gene clusters of eral other modular PKS clusters, including the pksX of
B. subtilis, TA antibiotic, mupirocin, pederin, and leina-lankacidin and lankamycin in Streptomyces rochei [38].
In the vicinity of orf19, two additional open reading mycin clusters [2, 42–45]. Discrete ATs are known for
some, but not all, of these. Recent work by Shen’s groupframes, orf21 and orf22, were identified (encoding an
ACP and an FkbH homolog, respectively). Although dis- [45] characterized the leinamycin AT biochemically and
showed that discrete ATs are evolutionarily distinct fromruptants of orf19 seemed to be able to produce both
lankacidin and lankamycin, the role of orf21 and orf22 integral ATs. These discrete ATs share a common evolu-
tionary origin, despite the fact that this class of PKSsin production of either antibiotic was not studied [38].
The lankacidin group of antibiotics contains a 3-car- is not confined to any particular group of bacteria. Thus,
there are two distinct classes of modular PKSs. Onebon unit that assumes different oxidation/reduction lev-
els in different antibiotic components, a pyruvate in class, including the classical DEBS system, contains
integral acyltransferases: a dedicated (integral) AT do-lankacidin and a D-lactate in lankacidinol [39]. It is con-
ceivable that the reaction scheme shown in Figure 5A, main appears in each module. This allows further chemi-
cal diversity by permitting the incorporation of differentcatalyzed by the enzymatic domains present in orf22,
orf21, and orf19, could apply to the lankacidin group of extender units in each extension reaction; typically these
are malonyl CoA or methylmalonyl CoA. The other classantibiotics. Utilization of all four domains (FkbH, ACP,
DH, and KR) would produce the 3-carbon unit found in uses discrete ATs: one or two separate AT enzymes that
serve multiple modules. Thus far, all of these are specificlankacidinol, while skipping the last reaction (i.e., the
-ketoreduction) will leave pyruvate at the same position for malonyl CoA (the expected extender unit for bryo-
statin). The relationship of bryA KSs with those of otherto form lankacidin. In this context, it is interesting to
note that the consensus for the glycine-rich NADP(H) modular PKSs that use a separate, discrete AT (Figure
4) is consistent with a requirement for a discrete AT forbinding motif, GXXXGXGXXXAXXXA, is well conserved
in the KR* in bryA, but less so in orf19 from S. rochei bryA function. As noted by Piel [46], it also suggests
that the discrete AT PKSs as a whole have distinct evolu-(data not shown). Production of lankacidin in orf19
mutants could be attributed to contribution from an un- tionary origins. We are currently screening the symbiont
genome for discrete AT domains.identified redundant protein present in this mutant that
compensates for the loss of the DH* activity. Alterna- BryA contains unusual and interesting features that
will be worth exploring in future studies. The high conser-tively, perhaps the construction of the mutant (which
was not described) did not eliminate the DH* activity. vation between shallow and deep sequences strengthens
the hypotheses that the “Candidatus E. sertula” PKSAnother case in which the reaction scheme shown in
Figure 5A may be functional is the biosynthesis of boron- cluster codes for enzymes involved in synthesis of the
bryopyran precursor of the bryostatins and that the di-containing antibiotic aplasmomycin produced by Strep-
tomyces griseus [40]. Labeling studies with various sub- versity of bryostatins is introduced by modifications
strates indicated that the biosynthetic precursor for the after synthesis of the bryopyran ring. It is obvious that
glycerol-derived starter unit of aplasmomycin is likely bryA functions as part of a much larger gene cluster in
phosphoglycerate or phosphoenolpyruvate [40]. In- the biosynthesis of a complete bryostatin, and we are
terestingly, this 3-carbon starter unit also has a config- in the process of characterizing other genes in the “Can-
uration of D-lactate. It is possible that our proposed didatus E. sertula” PKS cluster.
reaction scheme involving FkbH, DH*, KR*, and ACP
represents a common theme nature has developed for
Significanceincorporation of a glycolytic pathway intermediate into
polyketide biosynthesis.
Bryostatins are promising anticancer compounds,The methyltransferase domain in bryA is unusual in a
which are currently in clinical trials, but their availabil-modular PKS, and in this case, its function, if any, is
ity is limited. The biosynthetic source of bryostatinsunknown, but it has been seen in other polyketide syn-
is thought to be the bacterial symbiont, “Candidatusthases, for example in the epothilone gene cluster in
Sorangium cellulosom [32, 33]. In addition, the KRs of Endobugula sertula,” of the marine bryozoan Bugula
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tubes and centrifuged at 164  g for 15 min to pellet cell debris.neritina. “Candidatus E. sertula” is uncultivated, which
The supernatant was pipeted into a new tube and centrifuged athas led us to explore unconventional means to obtain
16,500  g for 15 min to pellet material of bacterial density. Theuseful amounts of bryostatin. One approach is to clone
pellet was resuspended in 5 ml lysis buffer and extracted as above.
genes involved in bryostatin synthesis for expression DNA was generally not visible upon precipitation, so instead of
in a cultivatable host. We have isolated a large gene spooling, it was pelleted, washed, and then resuspended in TE
buffer. Samples were then subjected to CsCl/ethidium bromide gra-cluster from “Candidatus E. sertula” that encodes a
dients as described above. After butanol extraction of ethidiummodular polyketide synthase (PKS) complex, which
bromide from the DNA, samples were run on 53% CsCl/Hoechstwe believe is responsible for bryostatin synthesis. We
33258 dye gradients (containing 10 g/ml dye), which separateshave characterized the first gene in this cluster, bryA,
DNA on the basis of GC content. The region of the gradient con-
and present a model for its involvement in synthesizing taining the bands (at least four were visible) was fractionated by
a portion of bryostatin. We propose that bryA encodes using a catheter attached to a peristaltic pump; for fine resolution,
70–140 l drops were collected. Individual fractions were dilutedthe bryostatin loading module, including an FkbH ho-
5-fold, and DNA was ethanol precipitated and resuspended in amolog domain that is involved in an uncommon, but
small volume. Fractions shown to contain the KSa gene by PCRpreviously documented, series of reactions to synthe-
were pooled and used for subsequent cloning or analysis.size the starter unit for bryostatin from a glycolytic
pathway intermediate to form D-lactate. The proposed
Competitor Construction and DNA Enrichment Assayscompound produced by the bryA gene product con-
To quantify “Candidatus E. sertula” DNA content by competitivetains most of the pharmacologically active portion of
PCR, a competitor of KSa (clone pSWA116) was constructed bybryostatin. Thus, expression of bryA in combination
generating a 60 bp internal deletion to allow resolution from the
with a suitable, discrete AT domain could serve as authentic fragment on an agarose gel [1]. Competitive PCR [48,
the basis for the semisynthesis of a compound with 49] was done with 200 ng of the DNA to be tested and different
concentrations of the pSWA116 clone in the same reaction mix.bryostatin-like qualities. The isolation of bryA repre-
KSa-specific primers were used to amplify products from nativesents a significant step forward in understanding bry-
copies of the gene (assay DNA) and varying amounts of pSWA116ostatin biosynthesis and eventually harnessing bry
(competitor) simultaneously. PCR products were separated on angenes to produce bryostatins and derivatives inexpen-
agarose gel, and conditions under which the full-length (assay DNA)
sively and in abundant quantities. and modified (pSWA116) products were equally abundant were de-
termined. Under these conditions, the amount of KSa in the assay
Experimental Procedures DNA and added pSWA116 were equal. Because the concentration
of pSWA116 was known, the amount in the assay DNA could be
Sample Collection and Genotype Determination calculated, allowing a comparison of enrichment of this gene frag-
Samples of Bugula neritina were collected by SCUBA diving from ment in the different samples tested [1].
three sites along the coast of San Diego, CA, USA; Mission Bay
(water depth5 m, sample not genotyped, but previous collections
determined to be type S), Scripps Pier (7 m, type S), and Torrey Cloning, Sequencing, and Sequence Analysis
Cloning DNA from Mission Bay B. neritinaPines Artificial Reef II (15 m, type D). The genotype of collected
specimens was determined by amplifying the 16S gene of “Candida- into Cosmid Vectors
Total DNA of B. neritina from Mission Bay was partially digested intus E. sertula” by PCR and digesting the product with the restriction
enzyme NheI. Due to a sequence polymorphism, the deep type is 2 g aliquots by using a dilution series of Sau3AI to determine
conditions yielding appropriate-sized (30–42 kbp) restriction frag-cut into two fragments, whereas the shallow type is not [47].
ments. Digests were then scaled up to 100 g DNA, and products
separated on 10%–40% sucrose gradients in a Beckman SW41DNA Isolation
Two methods were used for DNA isolation. The first, a “total” DNA rotor, for 22 hr at 22,000 rpm and 20	C. The gradient was fractionated
from the top by removing 350 l aliquots with a pipetman. Portionspreparation, was done by pulverizing 8 g aliquots of Bugula neritina,
frozen at 80	C, into a fine powder in a dry-ice pre-chilled mortar of each aliquot were analyzed by agarose gel electrophoresis, and
fractions containing DNA of the desired size were identified andand pestle. The powder was then added to 25 ml lysis buffer (50
mM Tris-HCl [pH 8.0], 50 mM Na2EDTA, 350 mM NaCl, 2% sodium pooled. DNA was ligated with BamHI-digested SuperCos I (Stra-
tagene, Inc.) and packaged into phage (Gigapack Gold III, Stra-sarcosyl, 8 M urea), mixed, and incubated at room temperature for
5 min. Ten ml phenol:chloroform (1:1) was added, and the solution tagene, Inc.), which were titered according to the manufacturer’s
instructions. After initial characterization of selected cosmid clones,very gently rotated (25 rpm) for 40 min to mix the layers. After
centrifugation to separate the layers, the aqueous layer was re- portions were subcloned into pBC (Stratagene, Inc.) by using stan-
dard procedures [50].moved with a wide-bore pipette into a new tube, and phenol:chloro-
form extracted for 20 min. The aqueous layer was removed, and Cloning DNA from Scripps Pier B. neritina
into Lambda DASH IIone-tenth volume of 3 M sodium acetate (pH 5.2) and an equal
volume of isopropanol were added and mixed. DNA immediately To isolate smaller portions of the putative bryostatin PKS cluster,
as well as to obtain more complete coverage, we recloned the regionprecipitated and was removed from the solution by spooling. Spool-
ing was superior to centrifugation because it reduced the amount into Lambda DASH II (Stratagene, Inc.), which accommodates frag-
ments of 9–23 kbp. Aliquots (3 g) of “enriched bacterial fraction”of a difficult-to-remove abundant pigment that co-pelleted with the
DNA. The spooled DNA was washed with 70% ethanol, resuspended Scripps pier (type S) DNA were partially digested with Sau3AI, and
one-third was electrophoresed on an agarose gel to assess thein TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM Na2EDTA), and then
subjected to 53% cesium chloride (CsCl)/ethidium bromide equilib- digestion. The remainder of digested DNA from conditions yielding
appropriate-sized fragments was then phenol:chloroform extracted,rium density gradient centrifugation. The resulting DNA band was
collected, the ethidium bromide was removed by butanol extraction, precipitated, washed, and resuspended in TE buffer. DNA was elec-
trophoresed on a 0.6% agarose gel, the region of the gel containingand the CsCl was removed by dialysis.
The second DNA isolation method, “enriched bacterial fraction,” fragments between 9 and 23 kbp was excised, and DNA was ex-
tracted by using a Marligen Rapid Gel Extraction kit. Recovery ofincorporated two steps designed to enrich for “Candidatus E. ser-
tula” DNA. Aliquots (33 g each, for a total of 133–166 g) of freshly DNA was estimated by running an aliquot on an agarose gel. The
appropriate amount of insert DNA was ligated with BamHI-digestedharvested B. neritina was added to 100 ml chilled artificial sea water
(ASW). Aliquots were homogenized for 1 min in a Polytron homoge- Lambda DASH II (Stratagene) vector, packaged into phage, and
titered, all according to the manufacturer’s instructions.nizer (model PCV11) at setting 4. The slurry was distributed into
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Cloning DNA from Torrey Pines Artificial Reef B. neritina
Table 2. Primers for RT-PCR in bryAinto Lambda ZAP
“Candidatus E. sertula”-enriched DNA isolated from Torrey Pines RT-PCR
Artificial Reef (type D) was used to construct a Lambda ZAP (Stra- Region Primer Name Sequence 5
-3

tagene, Inc.) library. Aliquots (2 g) were partially digested with
A BryA-DHLF GGAAGAAGTTGATTGGTTTTCASau3AI and electrophoresed on an agarose gel. The region between
BryA-DHLR CTCAACACCTTTACTCGCTATC4 and 6 kb was excised, and the DNA was isolated by using a Qiagen
B BryA-ACPLF CGCTAAAGTATTAGCGCGACGCGel Extraction kit. The DNA was then ligated with BamHI-digested
BryA-ACPLR ATTCGCTCTTTTTGATGCCTGCLambda ZAP vector and packaged into phage according to the
C BryA-KR1F CGCTCGTAAACTTGCAAACATGmanufacturer’s instructions.
BryA-KR1R TGTGTTGAATTCCAGCCGCATGLibrary Screening and Clone DNA Isolation
D BryA-MT3F GAACGTTTTGCTGCGATCCAFor the cosmid library, approximately 14,000 colonies were plated
BryA-MT3R GTCTCTTCTACATGAAAACCand lifts were made by using established procedures [50]. Filters
were screened with a radiolabeled probe derived from the KSa
PCR product. Radiolabeling was done by using -32P dCTP and a
Stratagene Prime-it II random priming kit. BLOTTO [42] in 2 SSC
enzymes were chosen based on their ability to cut the DNA intowas used as a blocking agent for prehybridization (2 hr, 55	C), and
appropriately sized fragments for use in Southern hybridizations.probe was then directly added to 1 106 cpm per ml for hybridization
The following single and double digests were performed: BamHI,at 55	C for 18 hr. Probe solution was removed, filters were rinsed
PstI, PstI/XhoI, SmaI, SmaI/NotI, XhoI/SalI, and SalI/EcoRI. The re-twice (5 min for each rinse) with 2SSC, 0.1% SDS at room tempera-
sulting fragments were electrophoresed on a 0.8% agarose gel andture, and filters were then washed twice (45 min for each wash)
transferred to Hybond-N nylon membrane (Amersham Pharmaciawith the same solution at 55	C. Filters were exposed to X-ray film
Biotech) by using standard protocols [50]. Based on the clonedovernight, which was then developed. A similar procedure was used
sequence, probes were designed to cover the entire bryA region.with the Lambda Dash and Lambda ZAP libraries, in which approxi-
These were generated by PCR amplification, and radiolabeling wasmately 40,000 and 50,000 plaques were screened, respectively.
done with -32P dCTP and a Stratagene Prime-it II random primingProbes for screening the Lambda libraries were derived from cosmid
kit. Southern hybridizations were performed according to standardfragments.
protocols [50], and localization of radioactive bands was visualizedDNA was isolated from cosmid clones by using a Qiagen miniprep
with a Typhoon 9410 Variable Mode Imager (Molecular Dynamics)procedure. DNA was isolated from lambda phage (DASH library) by
after an 18 hr exposure. Genomic and corresponding cloned DNAestablished procedures [50]. Plasmid rescue for Lambda ZAP clones
fragments were compared by size.was done according to the manufacturer’s instructions; DNA was
isolated from these plasmids by minipreps.
RNA Isolation and Reverse Transcription PCRCompletion of Deep bryA by PCR
Two 7.5 g aliquots of Scripps Pier (type S) adult B. neritina wereDue to a lack of Sau3AI sites, the first third of bryA was not present
homogenized in 20 ml artificial sea water with a Polytron homoge-in the Lambda ZAP library. This part of the gene had to be amplified
nizer. An enriched bacterial fraction was prepared as described forfrom total B. neritina DNA and TOPO-TA cloned (Invitrogen). The
DNA isolation. The cell pellet was resuspended in 3.1 ml Tri Reagentprimers were designed by using sequence information from the
(Sigma). RNA was isolated following the manufacturer’s instructionsshallow genotype. Possibly due to the extremely low GC content in
and resuspended in 500 l RNase-free water (Qiagen). In order tothis part of the gene (20%), amplification of more than 1 kb was
remove PCR inhibitors, the RNA was purified by using MicroSpinnot achievable, but four overlapping fragments were generated. The
S-400 HR columns (Amersham Biosciences) with 50 l RNA solutionPCR reactions were run by using the Expand Long Template PCR
per column. To remove contaminating DNA, purified RNA was thensystem (Roche) following manufacturer’s instructions.
treated with DNase I (Qiagen) on an RNeasy Mini Kit spin columnSequencing and Sequence Analysis
(Qiagen), as described by the manufacturer, and eluted with 30 lDNA from isolated clones was sequenced (2- to 3-fold coverage,
RNase-free water (Qiagen).both strands) on ABI 3100 automated DNA sequencers at the UCSD
cDNA was synthesized from 7 l DNase-treated RNA per reactionsequencing facilities in the Rebecca and John Moores UCSD Cancer
by using the SuperScript III First-Strand Synthesis System for RT-Center and Veterans Medical Research Foundation/UCSD Center
PCR (Invitrogen). Each reverse transcription reaction contained 1 lfor AIDS Research with vector-specific primers. Sequential sets of
of a 2 M gene-specific primer, BryA-DHLR, BryA-ACPLR, BryA-primers to extend the sequences were designed based on accumu-
KR1R, or BryA-MT3R (Table 2). A total of 10 l of the cDNA productlating sequence data.
was added to a 50 l PCR reaction containing 1 M of each primerSequence reads were assembled and analyzed with Sequencher
in the corresponding primer pair (Region A–D, Table 2), 1.25 U Taq(Gene Codes Corp.). Repeats were identified by dot plot analysis
DNA polymerase (Roche), 1 PCR reaction buffer (Roche), 0.5 ngin Vector NTI (Informax Inc.). Domains within the sequenced clones
BSA, and 0.2 mM dNTPs (Invitrogen). PCR reactions were donewere identified by homology with NCBI BLAST [30] and through
under the following conditions: one cycle of 1.5 min at 94	C; 30manual alignment with other known PKS domains.
cycles of 1 min at 94	C, 1 min at 60	C, 1 min at 72	C; and 1 cycleWe also analyzed the relationship between KS domains by
of 7 min at 72	C. RT-PCR products were run on a 1.2% agarose gelaligning the amino acid sequence of the BryA domains with those
and sequenced. To confirm that RT-PCR products reflected RNAfrom other modular Type I PKS gene clusters, as well as a Type II
content rather than DNA contamination, control RT-PCRs withoutPKS KS domain, by using CLUSTALW [51]. We performed phyloge-
reverse transcriptase were conducted for each primer pair.netic analysis with PAUP [52] and used distance as the optimality
criterion, heuristic search settings, and random addition of taxa.
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